Abstract
The t(14;18)(q32;q21) translocation is the most common translocation in B cell malignancies being found in 80% of follicular lymphomas and about 20% of diffuse large B cell lymphomas. Only rare cases of de novo acute B cell lymphoblastic leukemia with t(14;18) have been described. We describe five cases of this entity which appears to have very homogeneous clinical, phenotypic and genotypic features. None of these patients had prior history of follicular lymphoma. The disease was characterized by acute clinical features with nodal and/or extranodal disease, massive bone marrow infiltration and rapid increase of circulating blast cells of mature B cell phenotype. All patients disclosed complex chromosomal and molecular abnormalities involving at least the BCL-2 and c-MYC genes. Furthermore, three patients had evidence of BCL-6 involvement and one patient had a p53 mutation. Despite intensive chemotherapy, including for two patients allogeneic bone marrow transplantation in first complete remission, all patients died within a few months. Neuro-meningeal relapse occurred in three of the five patients in spite of neuro-meningeal prophylaxis. De novo leukemia/lymphoma with t(14;18) is a rare entity with a very poor prognosis. Whether early bone marrow transplant could modify the natural history of the disease remains to be determined. An intensive neuro-meningeal prophylaxis appears to be mandatory in these patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Yunis JJ, Oken MM, Kaplan ME, Ensrud KM, Howe RB, Theologides A . Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma New Engl J Med 1982 307: 1231–1236
Hubbard SM, Chabner BA, DeVita VT, Simon R, Berard CW, Jones RB, Garvin AJ, Canellos GP, Osborne CK, Young RC . Histologic progression in follicular lymphoma: a prospective study Blood 1982 59: 258–264
Yunis JJ, Frizzera G, Oken MM, McKenna J, Theologides A, Arnesen M . Multiple recurrent genomic defects in follicular lymphoma: A possible model for cancer New Engl J Med 1987 316: 79–84
Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES, Raffeld M . p53 mutation is associated with progression of follicular lymphomas Blood 1993 82: 1994–2004
Lee JT, Innes DJ, Williams ME . Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma J Clin Invest 1989 84: 1454–1459
Mufti GJ, Hamblin TJ, Oscier DG, Johnson S . Common ALL with pre-B-cell features showing (8;14) and (14;18) chromosome translocations Blood 1983 62: 1142–1146
Pegoraro L, Palumbo A, Erikson J, Falda M, Giovanazzo B, Emanuel BS, Rovera G, Nowell PC, Croce CM . A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia Proc Natl Acad Sci USA 1984 81: 7166–7170
Gluck WL, Bigner SH, Borowitz MJ, Brenckman WD . Acute lymphoblastic leukemia of Burkitt's type (L3 ALL) with 8;22 and 14;18 translocations and absent surface immunoglobulins Am J Clin Pathol 1986 85: 636–640
Thangavelu M, Olapade O, Beckman E, Vardiman JW, Larson R, McKeithan TW, LeBeau MM, Rowley JD . Clinical, morphologic and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18) (q32;q21) and t(8;14) (q24;q32) or t(8;22) q24; q11) Genes Chromosom Cancer 1990 2: 147–158
Kramer MHH, Raghoebier S, Beverstock GC, de Jong D, Kluin PM, Kluin-Nelemans JC . De novo acute B-cell leukemia with translocation t (14;18): an entity with a poor prognosis Leukemia 1991 5: 473–478
Brito-Babapulle V, Crawford A, Khokhar T, Laffan M, Matutes E, Fairhead S, Catovsky D . Translocations t (14;18) and t (8;14) with rearranged bcl-2 and c-myc in a case presenting as B-ALL (L3) Leukemia 1991 5: 83–87
Marosi C, Bettelheim P, Chott A, Köller U, Kreiner G, Steger G, Jäger V, Pirc-Danoewinata H, Lechner K . Simultaneous occurrence of t(14;18) and t(8;22) common acute lymphoblastic leukemia Ann Hematol 1992 64: 101–104
Nacheva E, Dyer MJS, Fischer P, Stranks G, Heward JM, Marcus RE, Grace C, Karpas A . C-myc translocation in de novo B-cell lineage acute leukemias with t (14;18) (cell lines Karpas 231 and 353) Blood 1993 82: 231–240
Karsan A, Gascoyne RD, Coupland RW, Shepherd JD, Phillips GL, Horsman DE . Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies Leuk Lymphoma 1993 10: 433–441
Van Ooteghem RBC, Smit EME, Beishuizen A, Lambrechts AC, Blij-Philipsen MVD, Smilde TJ, Hagemeijer A . A new B-cell line showing a complex translocation (8;14;18) and Bcl2 rearrangement Cancer Genet Cytogenet 1994 74: 87–94
Lillington DW, Monard S, Johnson PWM, Evans ML, Kearney LU, Lister TA, Young BD, Gibbons B . The t(14;18) in a patient with de novo acute lymphoblastic leukemia is associated with t(8;9) Leukemia 1994 8: 560–563
Berger R, Flexor M, Le Coniat M, Larsen CJ . Presence of three recurrent chromosomal rearrangements t(2;3)(p12;q37), del(8)(q24) and t(14;18) in an acute lymphoblastic leukemia Cancer Genet Cytogenet 1996 86: 76–79
Dyer MJS, Lillington DM, Bastard C, Tilly H, Lens D, Heward JM, Stranks G, Morilla R, Monard S, Guglielmi P, Kluin-Nelemans JC, Hagemeiyer A, Young BD, Catovsky D . Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus Leukemia 1996 10: 1198–1208
Dallery E, Galiège-Zouitina S, Collyn-d'Hooghe M, Quief S, Denis C, Hildebrand MP, Lantoine D, Deweinst C, Tilly H, Bastard C, Kerckaert JP . TTF a gene encoding a novel small G protein fuses to the lymphoma associated LAZ3 gene by t(3;4) translocation Oncogene 1997 14: 849–855
Haioun C, Lepage E, Gisselbrecht C, Coiffier B, Bosly A, Tilly H, Morel P, Nouvel C, Herbrecht R, D'Agay MF, Gaulard P, Reyes F for the groupe d'Etude des Lymphomes de l'adulte . Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients J Clin Oncol 1994 12: 2543–2551
Stamatoullas A, Fruchart C, Bastit D, Boulet D, Monconduit M, Piguet H, Tilly H . Ifosfamide, etoposide, cytarabine and methotrexae as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma Cancer 1996 11: 2302–2307
Coiffier B, Gisselbrecht C, Herbrecht R, Tilly H, Bosly A, Brousse N . LNH-84 regimen: a mulicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma J Clin Oncol 1989 7: 1018–1026
Bastard C, Tilly H, Lenormand B, Bigorgne C, Boulet D, Kunlin A, Monconduit M, Piguet H . Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma Blood 1992 79: 2527–2531
Deweindt C, Kerckaert JP, Tilly H, Quief S, Nguyen VC, Bastard C . Cloning of a breakpoint cluster region at band 3q27 in human non-Hodgkin's lymphoma Genes Chromosom Cancer 1993 8: 149–154
Kanavaros P, Lescs MC, Briere J, Divine M, Galateau F, Joab I, Bosq J, Farcet JP, Reyes F, Gaulard P . Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein–Barr virus Blood 1993 81: 2688–2695
Hamelin R, Jego N, Laurent-Puig P, Vidaud M, Thomas G . Efficient screening of p53 mutations by denaturating gradient gel electrophoresis in colorectal tumors Oncogene 1993 8: 2213–2220
De Jong D, Voetgijk BMH, Beverstock GC, Van Ommen GJB, Willemze R, Kluin PM . Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma New Engl J Med 1988 318: 1373–1378
Gauwerky EC, Haluska FG, Tsujimoto Y, Nowell PC, Croce CM . Evolution of B-cell malignancy: pre-B cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene Proc Natl Acad Sci USA 1988 85: 8548–8552
Lee JT, Innes DJ, Williams ME . Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma J Clin Invest 1989 84: 1454–1459
Yano T, Jaffe ES, Longo DL, Raffeld M . MYC rearrangements in histologically progressed follicular lymphoma Blood 1992 80: 758–767
Au WA, Gascoyne RD, Viswanatha DS, Skinninder BF, Connors JM, Klasa RJ, Horsman DE . Concurrent chromosomal alterations at 3q27, 8q24 and 18q21 in B-cell lymphomas Br J Haematol 1999 105: 437–440
Acknowledgements
This work was supported by the Comité Départemental de Seine-Maritime de la Ligue contre le Cancer.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stamatoullas, A., Buchonnet, G., Lepretre, S. et al. De novo acute B cell leukemia/lymphoma with t(14;18). Leukemia 14, 1960–1966 (2000). https://doi.org/10.1038/sj.leu.2401910
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401910
Keywords
This article is cited by
-
De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a case report and literature review
BMC Clinical Pathology (2017)
-
Double-hit lymphomas and complex variant translocations of t(14;18)(q32;q21.3)
Annals of Hematology (2013)
-
Concurrent translocation of BCL2 and MYC with a single immunoglobulin locus in high-grade B-cell lymphomas
Leukemia (2005)
-
Bax expression correlates with cellular drug sensitivity to doxorubicin, cyclophosphamide and chlorambucil but not fludarabine, cladribine or corticosteroids in B cell chronic lymphocytic leukemia
Leukemia (2002)
-
Suppression of apoptosis: role in cell growth and neoplasia
Leukemia (2001)